Web Results

caselaw.findlaw.com/us-8th-circuit/1669105.html

Jun 6, 2014 ... Kuhn v. Wyeth, 686 F.3d 618, 624 (8th Cir.2012). Although Minnesota law governs whether Johnson can ultimately prevail on the merits of this products liability action, the sole issue on appeal is the propriety of the district court's exclusion of Johnson's experts' reports. Admissibility of expert testimony is ...

www.supremecourt.gov/opinions/10pdf/09-152.pdf

Feb 22, 2011 ... BRUESEWITZ v. WYETH LLC. Syllabus provides that “[n]o vaccine manufacturer shall be liable in a civil ac- tion for damages arising from a vaccine-related injury or death asso- ciated with the administration of a vaccine after October ..... 42 See , e.g., Johnson v. American Cyanamid Co., 239 Kan. 279, 285,.

law.justia.com/cases/federal/district-courts/FSupp/666/1483/2150760

Alternatively, defendant contends that under Kansas laws as set forth in Johnson v. American Cyanamid, 239 Kan. 279, 718 P.2d 1318 (1986), this court must find as a matter of law that DPT vaccine is an "unavoidably unsafe" prescription drug which contains an adequate warning, and enter judgment in defendant's behalf.

www.coursehero.com/file/12532480/Chapter-7-IRACs

View Homework Help - Chapter 7 IRACs from MGMT 310 at New Mexico. IRAC Case 7.1 Bruesewitz v. Wyeth, LLC Issue: Defendant Bruesewitz was administered a vaccine produced by Wyeth LLC. Shortly after.

www.cafc.uscourts.gov/sites/default/files/opinions-orders/15-1871.Opinion.8-11-2016.1.PDF

Aug 16, 2016 ... JOHN J. MOLENDA, Steptoe & Johnson, LLP, New. York, NY, argued for appellant. ... that claims 1–23 of U.S. Patent 7,879,828 (“the '828 patent”) are not unpatentable as obvious. See Apotex Inc. v. Wyeth LLC, No. 2014-00115, 2015 WL 1848261, at *14. (P.T.A.B. Apr. 20, 2015). For the reasons that follow ...

media.ca8.uscourts.gov/opndir/17/07/163428U.pdf

Jun 6, 2017 ... Kuhn v. Wyeth, Inc., 686 F.3d 618, 624. (8th Cir. 2012). This same deferential standard of review applies even when the exclusion of the testimony will result in summary judgment in favor of one party. See. Gen. Elec. Co. v. Joiner, 522 U.S. 136, 142–43 (1997). District court judges "must ensure that any and ...

www.pacourts.us/assets/opinions/Supreme/out/J-69AandB-2011mo.pdf

Jan 21, 2014 ... Short-Form Complaint at ¶12, Lance v. Wyeth, Nov. Term 2006,. No. 000926. According to the complaint, Wyeth “owed a duty to [Catherine] not to introduce onto the market a drug that was unreasonably dangerous for any person to use,” and Redux was “so unreasonably dangerous and defective in design ...

www.jdsupra.com/legalnews/wyeth-v-levine-s-clear-evidence-19849

Feb 3, 2016 ... Interestingly, a currently pending certiorari petition, Johnson & Johnson v. Reckis, [33] raises issues under Wyeth but, as in that case, the state courts did not address any of the issues discussed in this article. Accordingly, the issue in Reckis appears to be only the narrow one of whether there was clear ...

www.law360.com/articles/676877/nj-is-no-exception-to-the-learned-intermediary-doctrine

Jul 9, 2015 ... Since the New Jersey Supreme Court's “revolutionary” decision in Perez v. Wyeth Laboratory Inc. in 1999 — holding that in direct to consumer marketing of pharmaceuticals the learned intermediary doctrine did not apply — no court applying New Jersey law has actually followed this rule, making the DTC ...